Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Amortization of Deferred Charges (2021 - 2025)

P3 Health Partners' Amortization of Deferred Charges history spans 4 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 72.43% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $13.6 million, up 71.7%, while the annual FY2025 figure was $13.6 million, 71.7% up from the prior year.
  • Amortization of Deferred Charges reached $2.2 million in Q4 2025 per PIIIW's latest filing, down from $11.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $11.0 million in Q3 2025 to a low of -$140000.0 in Q1 2024.
  • Average Amortization of Deferred Charges over 4 years is $1.5 million, with a median of $174197.5 recorded in 2021.
  • The largest YoY upside for Amortization of Deferred Charges was 11664.18% in 2024 against a maximum downside of 150.18% in 2024.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $1.3 million in 2021, then crashed by 94.73% to $67000.0 in 2023, then skyrocketed by 11664.18% to $7.9 million in 2024, then plummeted by 72.43% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Amortization of Deferred Charges are $2.2 million (Q4 2025), $11.0 million (Q3 2025), and $71000.0 (Q2 2025).